NCT06661694 - A Study to Learn How Different Tablets of the Study Medicine Mevrometostat Are Taken up Into the Blood in Healthy Adults | Biotech Hunter

Timeline

Start Date

April 28, 2025

Primary Completion Date

September 8, 2025

Study Completion Date

September 9, 2025

Conditions

Healthy

Interventions

DRUG

Treatment A

Single 875 mg dose of mevrometostat standard tablet formulation

DRUG

Treatment B

Single 875 mg dose of mevrometostat alternative tablet formulation

DRUG

Treatment C

Single 875 mg dose of mevrometostat alternative tablet formulation

DRUG

Treatment D

Single 875 mg dose of mevrometostat alternative tablet formulation

Trial Locations (1)

Pfizer Clinical Research Unit - Brussels, Brussels